News. 23/06/20

No wrongdoings on the part of Procuritas in Gram arbitration case

Today an arbitration award was delivered concerning the sale of the former Procuritas portfolio company Gram Equipment A/S to FSN Capital Fund V. A unanimous Arbitral Tribunal dismissed allegations that Procuritas acted fraudulently.

The Arbitral Tribunal, comprising Professor Torsten Iversen, Former President of the Danish Supreme Court Torben Melchior and Professor Mads Bryde Andersen, dismissed all accusations against persons associated with Procuritas. However, the Tribunal found reason to criticise certain circumstances in the target company Gram Equipment A/S, which is why the seller company Green Magnum S.A., was ordered to pay damages in this case. The length of the arbitration award is 429 pages.

Hans Wikse, Partner, Procuritas, is pleased that the tribunal did not place any fault upon Procuritas in terms of having misled FSN, but finds it regrettable that the Arbitral Tribunal has found that gross errors were committed in Gram Equipment A/S. He says that he appreciates the solid legal work of the Arbitral Tribunal, but that it is highly surprising that a seller company is to be held accountable for wrongdoings by Gram employees.

“The arbitration award entails that the seller has been found responsible for shortcomings of individuals in the target company as regards the disclosure of information during the sale process, while at the same time FSN’s claims in media against individuals associated with Procuritas are without any merit. We believe that certain parts of the arbitration award are surprising, for instance the individuals found responsible lacked motive as they jointly invested in the transaction together with FSN.

In 2017 FSN Capital Fund, through KG BidCo ApS, acquired Gram Equipment A/S from Green Magnum S.A., a Procuritas portfolio company. KG BidCo ApS later requested that the Arbitral Tribunal consider whether the seller had been fraudulent or acted with wilful misconduct.

“When sold in 2017, Gram Equipment A/S was a market leader, had a solid growth history and was well positioned for continued expansion. Company management believed completely and fully in the company’s future potential. FSN engaged a large number of advisors and was given every opportunity to perform thorough due diligence. It is regrettable that the Arbitral Tribunal has nevertheless found that such gross errors were committed within the target company,” says Hans Wikse.

For additional information, please contact:
Hans Wikse, Partner, Procuritas, Tel: +46 70 861 23 77

About Procuritas
Founded in 1986, Procuritas was the pioneer in introducing the concept of management buyouts in the Nordic region. Procuritas is currently investing PCI VI launched in 2017, with ca. MEUR 318 in committed capital, focusing on mid-sized companies in the Nordic region. With a passion for business, extensive industrial experience and more than thirty years’ track record covering a large variety of transactions, Procuritas has supported over 40 companies with the aim to accelerate their growth and realize their true business potential. Please visit Procuritas.com for more information on current and previous investments.

More news.

09/04/24

Polarn O. Pyret appoints Sara Sjöberg as new CEO

Procuritas Capital Investors VI (”Procuritas”), the Swedish private equity firm dedicated to growing Nordic mid-market enterprises, is delighted to announce the appointment of Sara Sjöberg as the forthcoming Chief Executive Officer for its portfolio company, Polarn O. Pyret, the iconic Swedish childrenswear brand. Sara Sjöberg steps into this role with a wealth of experience from...

 08/04/24

Humana to acquire Team Olivia’s Norwegian operation

Team Olivia, a leading care service provider in the Nordics has entered into an agreement to sell its Norwegian operations, Team Olivia Norge AS, to Human Care Holding AS (“Humana”). The Transaction is subject to approval by the Norwegian competition authority and is expected to be completed during the second quarter of 2024. Team Olivia,...

 28/02/24

Procuritas partners up with Precision BioLogic

Procuritas Capital Investors VII (Procuritas) acquires Precision BioLogic (PBI) and subsidiary (Affinity Biologicals), fast-growing niche leaders in hemostasis diagnostics and research. PBI has in recent years launched a number of successful diagnostics products and is active in a growing market, supported by long-term trends such as ageing population, emerging new therapies, and increased access to...